North America
C2N Building Case for Alzheimer's Dx as Aducanumab Approval Promises to Impact Testing Space
Premium
FDA's approval of the Biogen anti-amyloid Alzheimer's drug could drive demand for new tests for the disease, including potentially C2N's blood-based assay.
The recently launched digital health service allows patients to schedule sample collection for laboratory tests at their homes or offices.
FDA Warns Against Use of Innova Medical Group SARS-CoV-2 Antigen Test
Innova had been selling the test in the US despite never having received marketing approval, clearance, or authorization, according to the FDA.
AMP-led Expert Groups Release Clinical CYP2D6 Pharmacogenomic Testing Recommendation
The consensus guideline offers a two-tier categorization of alleles that are recommended for clinical CYP2D6 pharmacogenetic testing.
C2i Genomics, NovogeneAIT Genomics Partner to Launch Cancer Detection Platform in Southeast Asia
C2i's platform uses artificial intelligence pattern recognition and whole-genome analysis to detect minimal residual disease in blood samples from cancer patients.
Jun 10, 2021
LetsGetChecked Closes $150M Funding Round
Jun 8, 2021
Oncimmune Reports Jump in Fiscal 2021 Revenues
Jun 4, 2021
Jun 3, 2021